sb 216763 has been researched along with Pulmonary Disease, Chronic Obstructive in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baarsma, HA; Bos, S; Gosens, R; Kerstjens, HA; Langen, RC; Meurs, H; Schols, AM; Smit, M; Visser, KH | 1 |
| Baarsma, HA; de Theije, CC; Gosens, R; Haegens, A; Langen, RC; Pansters, NA; Remels, AH; Schols, AM; Verhees, KJ | 1 |
2 other study(ies) available for sb 216763 and Pulmonary Disease, Chronic Obstructive
| Article | Year |
|---|---|
Pharmacological inhibition of GSK-3 in a guinea pig model of LPS-induced pulmonary inflammation: I. Effects on lung remodeling and pathology.
Topics: Animals; beta Catenin; Collagen; Disease Models, Animal; Enzyme Inhibitors; Fibronectins; Glycogen Synthase Kinase 3; Guinea Pigs; Indoles; Lipopolysaccharides; Lung; Male; Maleimides; Muscle, Smooth; Pulmonary Disease, Chronic Obstructive; Signal Transduction; Smad Proteins | 2013 |
Pharmacological inhibition of GSK-3 in a guinea pig model of LPS-induced pulmonary inflammation: II. Effects on skeletal muscle atrophy.
Topics: Animals; Cell Differentiation; Cells, Cultured; Disease Models, Animal; Enzyme Inhibitors; Glucocorticoids; Glycogen Synthase Kinase 3; Guinea Pigs; Indoles; Lipopolysaccharides; Male; Maleimides; Muscle Development; Muscle, Skeletal; Muscular Atrophy; Pulmonary Disease, Chronic Obstructive; Tumor Necrosis Factor-alpha | 2013 |